Sganzerla Paolo, Cinelli Francesco, Capoferri Andrea, Rondi Mauro
Division of Cardiology, Department of Medical Sciences, ASST Bergamo Ovest, Ospedale di Treviglio, Treviglio, Bergamo, Italy.
Eur Heart J Case Rep. 2020 Oct 21;4(6):1-5. doi: 10.1093/ehjcr/ytaa281. eCollection 2020 Dec.
Percutaneous circulatory support allows the performance of coronary interventions in ever more complex anatomic and clinical situations. The large-bore systems currently available need a suitable vascular calibre to be inserted restricting percutaneous access mainly to the common femoral artery.
We present the case of a 64-year-old man, admitted with an acute coronary syndrome and congestive heart failure, due to triple-vessel coronary artery disease with left main involvement and left ventricular dysfunction. He was successfully treated with percutaneous coronary intervention (PCI) supported through an IMPELLA 2.5L circulatory system. Concomitant severe and diffuse peripheral vascular disease did not allow femoral insertion of the circulatory support which was therefore successfully introduced through a left brachial percutaneous approach.
To the best of our knowledge, this is the first report of a brachial, percutaneous placement of the IMPELLA 2.5L system to support a high-risk PCI procedure. In appropriately selected patients, this approach could be an option when common vascular accesses are not available.
经皮循环支持使得在越来越复杂的解剖和临床情况下进行冠状动脉介入治疗成为可能。目前可用的大口径系统需要合适的血管管径才能插入,这主要限制了经皮穿刺途径,使其主要局限于股总动脉。
我们报告了一名64岁男性患者的病例,该患者因三支冠状动脉疾病累及左主干且伴有左心室功能障碍,出现急性冠状动脉综合征和充血性心力衰竭而入院。他通过IMPELLA 2.5L循环系统支持的经皮冠状动脉介入治疗(PCI)获得成功治疗。同时存在的严重弥漫性外周血管疾病不允许经股动脉插入循环支持装置,因此通过左肱动脉经皮途径成功引入该装置。
据我们所知,这是首次关于经肱动脉经皮置入IMPELLA 2.5L系统以支持高风险PCI手术的报道。在适当选择的患者中,当无法获得常用血管通路时,这种方法可能是一种选择。